Prolonged evolution of the human B cell response to SARS-CoV-2 infection

Sakharkar, Mrunal, Rappazzo, C. Garrett, Wieland-Alter, Wendy F., Hsieh, Ching-Lin, Wrapp, Daniel, Esterman, Emma S., Kaku, Chengzi I., Wec, Anna Z. +5 more·2021·Science Immunology

DOI 10.1126/sciimmunol.abg6916

Cited by (175)

Items 101–175 of 175

Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants
Marianna Agudelo, Frauke Muecksch, Dennis J. Schaefer-Babajew, Alice Cho, Justin DaSilva, Eva Bednarski, Víctor Ramos, Thiago Y. Oliveira, Melissa Cipolla, Anna Gazumyan et al. · 2022 · The Journal of Experimental Medicine
Associations between Allelic Variants of the Human IgH 3′ Regulatory Region 1 and the Immune Response to BNT162b2 mRNA Vaccine
Mattia Colucci, Elisabetta De Santis, Beatrice Totti, Mattia Miroballo, Francesco Tamiro, Giovanni Rossi, Ada Piepoli, Gabriella De Vincentis, Antonio Greco, Alessandra Mangia et al. · 2021 · Vaccines
High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection
Antonio Facciuolo, Erin Scruten, Sean Lipsit, Amanda L. S. Lang, Zoë Parker Cates, Jocelyne M. Lew, Darryl Falzarano, Volker Gerdts, ANTHONY J. KUSALIK, Scott Napper · 2022 · Scientific Reports
Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination
Mizuki Fujisawa, Taishi Onodera, Daisuke Kuroda, Chidchamai Kewcharoenwong, Michihito Sasaki, Yukari Itakura, Kohei Yumoto, Arnone Nithichanon, Naoto Ito, Shinji Takeoka et al. · 2025 · npj Vaccines
Infant Antibody Repertoires during the First Two Years of Influenza Vaccination
Masayuki Kuraoka, Nicholas C. Curtis, Akiko Watanabe, Hidetaka Tanno, Seungmin Shin, Kevin Ye, Elizabeth A. MacDonald, Olivia Lavidor, Susan Kong, Tarra A. Von Holle et al. · 2022 · mBio
Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents
Zheng Wang, Dan Li, Yulu Chen, Yeping Sun, Changzhong Jin, Caiqin Hu, Yi Feng, Junwei Su, Li Ren, Yanling Hao et al. · 2023 · Frontiers in Immunology
Humoral and cellular immunity against diverse SARS-CoV-2 variants
Changxu Chen, Xin Wang, Zeli Zhang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches
Olga A. Tarasova, Anthi Petrou, Sergey M. Ivanov, Athina A. Geronikaki, Vladimir Poroikov · 2024 · International Journal of Molecular Sciences
Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants
Kiyomi Shitaoka, Akifumi Higashiura, Yohei Kawano, Akima Yamamoto, Yoko Mizoguchi, Takao Hashiguchi, Norihisa Nishimichi, Shiyu Huang, Ayano Ito, Shun Ohki et al. · 2023 · Communications Biology
SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination
Shishan Teng, Yabin Hu, You Wang, Yinggen Tang, Qian Wu, Xingyu Zheng, Rui Lü, Dong Pan, Fen Liu, Tianyi Xie et al. · 2024 · Frontiers in Immunology
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
Ruth I. Connor, Mrunal Sakharkar, Garrett Rappazzo, Chengzi I. Kaku, Nicholas C. Curtis, Seungmin Shin, Wendy Wieland‐Alter, Jordan Wentworth, Daniel W. Mielcarz, Joshua A. Weiner et al. · 2024 · Pathogens and Immunity
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
C. Kaku, Alan J. Bergeron, C. Ahlm, J. Normark, M. Sakharkar, M. Forsell, L. Walker · 2022 · bioRxiv
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets
Asmaa Hachim, Niloufar Kavian, Sophie A. Valkenburg · 2021 · Current Opinion in Virology
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
Money Gupta, Harikrishnan Balachandran, Raymond H. Y. Louie, Hui Li, David Agapiou, Elizabeth Keoshkerian, Daniel Christ, William D. Rawlinson, Michael Mina, Jeffrey John Post et al. · 2022 · Immunology and Cell Biology
The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2
Meng Yuan, Ian A. Wilson · 2024 · Vaccines
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines
David Hodgson, Yi Liu, Louise A. Carolan, Siddhartha Mahanty, Kanta Subbarao, Sheena G. Sullivan, Annette Fox, Adam J. Kucharski · 2025 · Frontiers in Immunology
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
Mikako Ueno, Naoko Iwata‐Yoshikawa, Akihiro Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, Isao Yoshida, Mami Nagashima, Hiroyuki Asakura, Yu Yaoita et al. · 2022 · Antiviral Research
SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination
Tom Moore, Rojony Hossain, Katie J. Doores, Manu Shankar‐Hari, David J. Fear · 2022 · Viral Immunology
Topography of the HLA-A protein enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients
John T. Killian, Rodney Glenn King, Aaron C. K. Lucander, James L. Kizziah, Christopher Fucile, Rubén Díaz-Avalos, Shihong Qiu, Aarón Silva-Sánchez, Betty J. Mousseau, Kevin J. Macon et al. · 2025 · Immunity
Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helix
Haoneng Tang, Yong Ke, Yunji Liao, Yanlin Bian, Yunsheng Yuan, Ziqi Wang, Yang Li, Hang Ma, Tao Sun, Baohong Zhang et al. · 2022 · Virologica Sinica
Germline-encoded specificities and the predictability of the B cell response
Marcos C. Vieira, Anna-Karin E. Palm, Christopher T. Stamper, Micah E. Tepora, Khoa D. Nguyen, Tho D. Pham, Scott Dexter Boyd, Patrick C. Wilson, Sarah E. Cobey · 2023 · PLoS Pathogens
A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls
Xixian Chen, Ling Li, Ruiping Du, Zuowei Wang, Yunjian Li, Yi Sun, Rongrong Qin, Hualong Feng, Lin Hu, Xuanyi Chen et al. · 2025 · Cell Reports
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19
Xing Fan, Jin‐Wen Song, Wenjing Cao, Ming‐Ju Zhou, Tao Yang, Jing Wang, Fan-Ping Meng, Ming Shi, Chao Zhang, Fu‐Sheng Wang · 2024 · Viruses
Passive Immunity Should and Will Work for COVID-19 for Some Patients
Nevio Cimolai · 2021 · Clinical Hematology International
A recurring YYDRxG pattern in broadly neutralizing antibodies to a conserved site on SARS-CoV-2, variants of concern, and related viruses
Hejun Liu, Chengzi I. Kaku, Ge Song, Meng Yuan, Raiees Andrabi, Dennis R. Burton, Laura M. Walker, Ian A. Wilson · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
Timothy A. Bates, Hans C. Leier, Savannah K. McBride, Devin Schoen, Zoë L. Lyski, David Xthona Lee, William B. Messer, Marcel E. Curlin, Fikadu Tafesse · 2023 · medRxiv
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2
Yupeng Feng, Meng Yuan, John M. Powers, Mengyun Hu, Jennifer E. Munt, Prabhu S. Arunachalam, Sarah R. Leist, Lorenza Bellusci, Lily E. Adams, Sumana Sundaramurthy et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
Eduardo Tosta · 2021 · Exploration of Immunology
Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study
Qiao Guo, Lei Yang, Ran Peng, Tao Gao, Xinglin Chu, Depeng Jiang, Dazhi Ke, Hong Gang Ren · 2022 · Frontiers in Public Health
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals
Aurélien Sokal, Giovanna Barba Spaeth, Ignacio Fernández, Matteo Broketa, Imane Azzaoui, Andrea de La Selle, Alexis Vandenberghe, Slim Fourati, Anaïs Roeser, Annalisa Meola et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance
Yuichiro Yamamoto, Kohji Noguchi · 2025 · Biomolecules
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, 김연수, Luiz Gustavo Teixeira Alves, Upasana Kulkarni, Kathrin Eschke, M. Zeeshan Chaudhry, Markus Hoffmann, Federico Bertoglio, Maximilian Ruschig et al. · 2024 · Frontiers in Immunology
To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
Poor immune response to inactivated COVID-19 vaccine in patients with hypertension
Lei Yang, Zhihuan Zhang, Qiao Guo, Lei Yang, Hong Ren · 2024 · Frontiers in Medicine
Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients
Krystallenia Paniskaki, Moritz Anft, Constantin J. Thieme, Sarah Skrzypczyk, Margarethe Konik, Sebastian Dolff, Timm Henning Westhoff, Mikalai Nienen, Anna Stittrich, Ulrik Stervbo et al. · 2022 · Transplantation Proceedings
B cell–reactive neoantigens boost antitumor immunity
Jeong Yeon Kim, Jinhyeon An, So-Yeon Kim, Hye-Yeong Jo, Eun Ji Lee, Min Ju Kim, Hongui Cha, Se‐Hoon Lee, Hyun‐Young Park, Sang Cheol Kim et al. · 2025 · Science Advances
Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
Antonio Facciuolo, Jill van Kessel, Andrea Kroeker, Mingmin Liao, Jocelyne M. Lew, Darryl Falzarano, Alyson A. Kelvin, Volker Gerdts, Scott Napper · 2023 · Frontiers in Microbiology
Mechanisms Promoting Stability of B Cells
Vivian L. S. Kuan, Jayanta Chaudhuri · 2025 · Immunological Reviews
Antibodies as drugs—a Keystone Symposia report
Jennifer Cable, Erica Ollmann Saphire, Adrian Hayday, Timothy D. Wiltshire, Jarrod J. Mousa, David P. Humphreys, Esther C.W. Breij, Pierre Bruhns, Matteo Broketa, Genta Furuya et al. · 2022 · Annals of the New York Academy of Sciences
Nonlinear interdependence of the results of measuring anti-SARS-CoV-2 IgG levels using Abbott and Euroimmun test systems
А. В. Иванов, E. Kryshen, E. V. Semenova · 2023 · Journal of Clinical Virology
Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
Liise‐anne Pirofski · 2021 · Clinical Infectious Diseases
Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
Elaine C. Chen, Pavlo Gilchuk, Seth J. Zost, Philipp A. Ilinykh, Elad Binshtein, Kai Huang, Luke Myers, Stefano R. Bonissone, Samuel Day, Chandrahaas R. Kona et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Characterization of SARS-CoV-2 Convalescent Patients’ Serological Repertoire Reveals High Prevalence of Iso–RBD Antibodies
Nicholas C. Curtis, Seungmin Shin, Andrew P. Hederman, Ruth I. Connor, Wendy Wieland‐Alter, Steven Ionov, Jennifer A. Boylston, Josh Rose, Mrunal Sakharkar, Dana B. Dorman et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
B cells imprinted by ancestral SARS-CoV-2 develop pan-sarbecovirus neutralization in immune recalls
Xixian Chen, Ling Li, Ruiping Du, Zuowei Wang, Yunjian Li, Yi Sun, Rongrong Qin, Hualong Feng, Lin Hu, Xuanyi Chen et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Humoral Immune Response to Orientia tsutsugamushi Infection: Recent Research Findings and Future Studies
Casey Gonzales, Lynn Soong · 2025 · Zoonoses
Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery
Luciana Conde, Debora Leite Oliveira, Gabriela Maciel, Fernando Castro, Aline Albuquerque, D. A. Rodrigues, Yare Mello, Gustavo Meira de Asis, Bárbara Gabrielle, Suyane S Ferreira et al. · 2025 · The Journal of Immunology
Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases
Lei Yang, LingFang Xu, Qiao Guo, Bing Deng, Yang Hong, Liangliang Wang, YaLin Wang, Depeng Jiang, Hong Ren · 2023 · International Journal of Medical Sciences
Sustained immunological memory to SARS-CoV-2 antigens. Three years of observation
Zulfiia E. Afridonova, А. П. Топтыгина, Elena L. Semikina · 2024 · Russian Journal of Infection and Immunity
Sputnik V-Induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela
Christopher D. Franco, Alejandro Cornejo, Mariajosé Rodríguez, Alexis Hipólito García, Inírida Belisario, Soriuska José Mayora, Alexis García, Rossana Celeste Jaspe, Mariana Hidalgo, Nereida Parra-Giménez et al. · 2024 · Viruses
COVID ‐19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID ‐19 pediatric convalescents
Michael Gurevich, Rina Zilkha‐Falb, Polina Sonis, David Magalashvili, Mark Dolev, Mathilda Mandel, Shay Menascu, Anat Achiron · 2022 · Pediatric Allergy and Immunology
Overview of the neutralizing antibody and memory B cell response kinetics in SARS-CoV-2 convalescent and/or mRNA vaccinated individuals.
Irina Grigorova · 2021 · System Biology and Physiology Reports
COVID cure or perpetual vaccination?: 30 cheap effective treatments of COVID-19 & variants, like ivermectin, or never-ending compulsory injection, with unsafe, genotoxic, infertilizing, injuring, crippling, handicapping, lethal, inefficient, ineffective, abortion-tainted, abortive, unethical, experimental genetic-hacks, deceivingly called vaccines instead of haccines? Scientific proof of the COVID PLANdemic with 2000 peer reviewed published references.
Federico A. Nazar · 2021
Persistent Maintenance of Atypical Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
Jernej Pušnik, Julia König, Karola Mai, Enrico Richter, Jasmin Zorn, Hannah Proksch, Bianca Schulte, Galit Alter, Hendrik Streeck · 2022 · SSRN Electronic Journal
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer
L. Măruțescu, Alexandru Enea, Nefeli-Maria Antoniadis, Marian Neculae, D. Costea, Marcela Popa, Elena Dragu, Elena Codrici, Violeta Ristoiu, B. Gălățeanu et al. · 2025 · Viruses
Dominant and cross-reactive S1-specific memory B cell response induced by primary SARS-CoV-2 infection
Xiaomin Xing, Zhaoyong Zhang, Yingfen Wen, Wenjing Guo, Xulei Zhang, Yuyi Min, Kexin Zhong, Lu Zhang, Peilan Wei, Shengnan Zhang et al. · 2025 · Scientific Reports
Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants
Huibin Lv, Ziqi Feng, Qi Wen Teo, Chunke Chen, Akshita Baiju Gopal, Danbi Choi, Timothy J.C. Tan, Yun Sang Tang, Lewis Yu-Lam Siu, Armita Nourmohammad et al. · 2026 · Advanced Science
Modeling immunodominance in the B-cell response to viral infection
Nikolay M. Bessonov, Gennady Alekseevich Bocharov, Daria Neverova, Vitaly A Volpert · 2023 · Mathematics and Mechanics of Complex Systems
Multiparametric analysis of the specific immune response against SARS-CoV-2
Lucie Vránová, Ingrid Poláková, Šárka Vaníková, Martina Saláková, Jan Musil, Marie Vaníčková, Ondřej Vencálek, Michal Holub, Miloš Bohoněk, David Řezáč et al. · 2024 · Scandinavian Journal of Infectious Diseases
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
Mark Chernyshev, Mrunal Sakharkar, Ruth I. Connor, Haley L. Dugan, Daniel J. Sheward, C. Garrett Rappazzo, Aron Stålmarck, Mattias N.E. Forsell, Peter F. Wright, Martin Corcoran et al. · 2022 · Research Square
Dissecting the impact of somatic hypermutation on SARS-CoV-2 neutralization and viral escape
M. Korenkov, Matthias Zehner, H. Cohen-Dvashi, A. Borenstein-Katz, Lisa Kottege, H. Janicki, K. Vanshylla, Timm Weber, H. Gruell, M. Koch et al. · 2023 · bioRxiv
Mémoire immunitaire contre le SARS-CoV-2
Claude–Agnès Reynaud, Jean–Claude Weill, Pascal Chappert, Matthieu Mahévas · 2021 · médecine/sciences
Fate and plasticity of SARS-CoV-2-specific B cells during memory and recall response in humans
Yves Zurbuchen, Jan Michler, Patrick Taeschler, Sarah Adamo, Carlo Cervia, Miro E. Raeber, İlhan E. Acar, Jakob Nilsson, Klaus Warnatz, Michael Soyka et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Impacts of viral pathogenesis and vaccine immunization on the host humoral immune response in SARS-CoV-2 and associated variants of concern (VOCs) infection
Sougata Roy Chowdhury, Subhendu Chakrabarty, Modhurima Chakraborti, Amlan Kumar Das · 2023 · Elsevier eBooks
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Lei Yang, Yaming Liu, Qiao Guo, Depeng Jiang · 2023 · Open Medicine
Identificação de peptídeos-alvo de anticorpos contra a proteína RBD do vírus SARS-CoV-2 em indivíduos convalescentes e vacinados
Jamille Ramos de Oliveira · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
Immunoglobulin Clonotype and Ontogeny Inference
Pazit Polak, Ramit Mehr, Gur Yaari · 2024 · Elsevier eBooks
SPATIOTEMPORAL DYNAMICS IN A MODEL OF IMMUNODOMINANCE
Nayana Mukherjee, Vitaly A Volpert · 2024 · Journal of Biological Systems
Computational approaches to study germline-encoded and expressed adaptive immune receptor repertoires
Mark Chernyshev · 2025
SARS-CoV-2 bermutasi, juga antibodi. Tapi kenapa harus divaksin dan terapkan protokol kesehatan?
Rama Dhenni · 2021
Longitudinal dynamics of humoral immune responses following serial COVID-19 vaccinations and breakthrough infections in dialysis patients
Wan‐Chuan Tsai, Fang‐Yeh Chu, Yen‐Ling Chiu, Hon‐Yen Wu, Ju‐Yeh Yang, Mei‐Fen Pai, Shih‐Ping Hsu, Kuei‐Ting Tung, Kai‐Hsiang Shu, Wan‐Yu Lin et al. · 2025 · Human Vaccines & Immunotherapeutics
The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response
Suncheol Park, Jacob Mischka, Nisreen M.A. Okba, Anass Abbad, Meng Yuan, Komal Srivastava, Charles Gleason, Lubbertus C. F. Mulder, Jeffrey Copps, Katrina Saam et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
Aurélien Sokal · 2022 · theses.fr (ABES)
Seroepidemiology of emerging viruses in Bolivia
Lucia Inchauste Jordan · 2023 · theses.fr (ABES)
mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model
Ashwin N. Skelly, Chengcheng Fan, Jennifer R. Keeffe, Arya B. Ökten, Edem Gavor, Maddy L. Newby, Joel D. Allen, Edward F. Kreider, Wenge Ding, Rebecca A Osbaldeston et al. · 2026 · Proceedings of the National Academy of Sciences
Longitudinal BCR repertoire dynamics reveal the evolution of broadly binding antibodies following heterologous SARS-CoV-2 vaccination and breakthrough infection: a single-donor case study
Rui Qiao, Xiaorong Chen, Xuhuan Zhang, Yuchen Shao, Liangjiu Zhang, Luxuan Yang, Yabo Mi, Yinying Lu, Jiayan Li, Yumeng Chen et al. · 2026 · Emerging Microbes & Infections